Bayer Aktiengesellschaft (FRA:BAYN)

Market Cap	48.39B +72.5%
Revenue (ttm)	45.38B -1.7%
Net Income	-1.74B
EPS	-1.77
Shares Out	n/a
PE Ratio	n/a
Forward PE	10.57
Dividend	0.11 (0.22%)
Ex-Dividend Date	Apr 27, 2026

Volume	151
Open	49.39
Previous Close	49.10
Day's Range	49.00 - 49.76
52-Week Range	25.80 - 53.74
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 4, 2026

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and ge...

• Industry: Chemicals and Allied Products
• Founded: 1863
• Employees: 87,830
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: BAYN

Financial Performance

In 2025, Bayer Aktiengesellschaft's revenue was 45.58 billion, a decrease of -2.21% compared to the previous year's 46.61 billion. Losses were -3.62 billion, 41.8% more than in 2024.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 26, 2026

Data Sources Report a data error